Skip to content

Effects of goal-directed fluid therapy combined with norepinephrine on tissue oxygen metabolism in elderly patients undergoing single hip or knee replacement

Effects of goal-directed fluid therapy combined with norepinephrine on tissue oxygen metabolism in elderly patients undergoing single hip or knee replacement

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038215
Enrollment
Unknown
Registered
2020-09-14
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral hip or knee replacement

Interventions

experimental group:Goal-directed fluid therapy combined with norepinephrine
control group:Conventional infusion

Sponsors

University-Town Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with age >= 60 years who are proposed to undergo single hip or knee replacement under general anesthesia; Preoperative ASA class I - III; 2. 18 kg/m2 or less BMI 25 kg/m2 or less; 3. Patients with informed consent can cooperate with process implementation.

Exclusion criteria

Exclusion criteria: 1. There was severe liver and kidney dysfunction before operation (liver enzyme was 3 times higher than the upper limit of normal value, Cr or BUN was higher than the upper limit of normal value); 2. Serious cardiovascular disease, cardiac insufficiency NYHA III level or higher, unstable angina, heart failure, etc.); 3. Severe bradycardia (heart rate less than 50 beats/min), severe arrhythmias (such as ventricular fibrillation, atrial fibrillation, frequent ventricular premature beats, frequent atrial premature beats, etc.), severe conduction block, peripheral vascular diseases; 4. Preoperative history of thromboembolism; 5. Preoperative HCT <= 30%, Hb < 100g/L; 6. The presence of mental illness before surgery; 7. Hearing impairment, difficulty in language communication; 8. Allergic to the drugs used in this study.

Design outcomes

Primary

MeasureTime frame
Arterial blood gas analysis;Venous blood gas analysis;Blood pressure;Heart rate;

Secondary

MeasureTime frame
Total amount of input liquid;

Countries

China

Contacts

Public ContactYao Yuting

University-Town Hospital of Chongqing Medical University

1045213947@qq.com+86 15881406873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026